| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,249 |
19,529 |
$1.04M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,335 |
12,089 |
$845K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
9,395 |
9,074 |
$372K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
395 |
238 |
$217K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,578 |
2,478 |
$213K |
| X5622 |
|
3,561 |
3,434 |
$172K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,423 |
2,378 |
$170K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,870 |
2,713 |
$156K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,043 |
1,970 |
$129K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,052 |
3,917 |
$111K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,298 |
4,176 |
$57K |
| 90461 |
|
2,136 |
2,076 |
$46K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,608 |
1,548 |
$38K |
| 99215 |
Prolong outpt/office vis |
385 |
358 |
$38K |
| 99188 |
|
4,392 |
4,277 |
$37K |
| 36415 |
Collection of venous blood by venipuncture |
9,908 |
9,085 |
$32K |
| 0002A |
|
1,281 |
1,264 |
$32K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
980 |
946 |
$31K |
| 0001A |
|
1,385 |
1,367 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,849 |
1,040 |
$25K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,459 |
1,420 |
$25K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
303 |
300 |
$23K |
| 90834 |
Psychotherapy, 45 minutes with patient |
435 |
241 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
144 |
140 |
$16K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
277 |
268 |
$15K |
| 92551 |
|
2,226 |
2,175 |
$14K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,950 |
2,253 |
$14K |
| 90686 |
|
2,956 |
2,873 |
$11K |
| 0004A |
|
239 |
235 |
$9K |
| 87650 |
|
569 |
542 |
$8K |
| 0054A |
|
242 |
217 |
$8K |
| 0072A |
|
192 |
192 |
$8K |
| 0071A |
|
224 |
187 |
$8K |
| 91320 |
|
85 |
85 |
$8K |
| 96127 |
|
1,935 |
1,786 |
$7K |
| 95874 |
|
187 |
167 |
$7K |
| 99243 |
|
74 |
73 |
$5K |
| 90480 |
|
166 |
162 |
$5K |
| 80061 |
Lipid panel |
375 |
365 |
$5K |
| 90670 |
|
1,450 |
1,421 |
$5K |
| 80053 |
Comprehensive metabolic panel |
455 |
438 |
$4K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
18 |
12 |
$4K |
| 95117 |
|
529 |
278 |
$4K |
| 0064A |
|
80 |
80 |
$3K |
| 0082A |
|
96 |
76 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
109 |
103 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
188 |
183 |
$3K |
| 99173 |
|
2,248 |
2,198 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
285 |
274 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
343 |
328 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
147 |
141 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
58 |
50 |
$2K |
| 85027 |
|
354 |
345 |
$2K |
| 85018 |
|
1,005 |
974 |
$2K |
| 0124A |
|
59 |
57 |
$2K |
| 99000 |
|
114 |
113 |
$2K |
| 99442 |
|
45 |
27 |
$1K |
| 77080 |
|
66 |
64 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$1K |
| 0083A |
|
31 |
28 |
$1K |
| 0081A |
|
38 |
32 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
138 |
130 |
$1K |
| 90688 |
|
488 |
480 |
$1K |
| 92557 |
|
45 |
44 |
$948.00 |
| 64615 |
|
13 |
12 |
$920.13 |
| 96161 |
|
477 |
448 |
$814.20 |
| 99421 |
|
85 |
79 |
$791.77 |
| 0074A |
|
15 |
15 |
$621.98 |
| 90656 |
|
310 |
309 |
$504.26 |
| 36416 |
|
145 |
132 |
$473.09 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$459.78 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$459.78 |
| 83655 |
|
29 |
29 |
$352.00 |
| 73562 |
|
16 |
12 |
$349.32 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
50 |
49 |
$303.55 |
| 99441 |
|
15 |
13 |
$294.12 |
| 92567 |
|
28 |
26 |
$284.28 |
| 81001 |
|
84 |
84 |
$259.12 |
| 90473 |
|
12 |
12 |
$254.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$244.12 |
| 87186 |
|
40 |
28 |
$226.82 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25 |
25 |
$204.52 |
| G0008 |
Administration of influenza virus vaccine |
20 |
20 |
$195.11 |
| 90680 |
|
329 |
323 |
$186.80 |
| 90723 |
|
606 |
591 |
$176.62 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
61 |
43 |
$176.61 |
| 87807 |
|
13 |
12 |
$159.80 |
| 87210 |
|
25 |
24 |
$145.89 |
| 92550 |
|
12 |
12 |
$116.24 |
| 82043 |
|
13 |
13 |
$76.26 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
109 |
106 |
$64.62 |
| 85652 |
|
15 |
14 |
$41.63 |
| 90648 |
|
1,227 |
1,199 |
$31.43 |
| 81003 |
|
13 |
12 |
$26.90 |
| 90697 |
|
30 |
29 |
$0.00 |
| 90677 |
|
61 |
60 |
$0.00 |
| 91319 |
|
12 |
12 |
$0.00 |
| 90633 |
|
109 |
107 |
$0.00 |
| 91300 |
|
515 |
464 |
$0.00 |
| 90685 |
|
244 |
240 |
$0.00 |
| 90715 |
|
13 |
12 |
$0.00 |